Your browser doesn't support javascript.
loading
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
Schwartz, Gregory G; Bessac, Laurence; Berdan, Lisa G; Bhatt, Deepak L; Bittner, Vera; Diaz, Rafael; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Mahaffey, Kenneth W; Moryusef, Angèle; Pordy, Robert; Roe, Matthew T; Rorick, Tyrus; Sasiela, William J; Shirodaria, Cheerag; Szarek, Michael; Tamby, Jean-François; Tricoci, Pierluigi; White, Harvey; Zeiher, Andreas; Steg, Philippe Gabriel.
Afiliação
  • Schwartz GG; University of Colorado School of Medicine, Denver, CO. Electronic address: Gregory.Schwartz@va.gov.
  • Bessac L; Sanofi-Aventis Recherche et Développement S.A., Paris, France; Sanofi-Aventis Recherche et Développement S.A., Bridgewater, NJ.
  • Berdan LG; Duke Clinical Research Institute, Durham, NC.
  • Bhatt DL; Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Bittner V; University of Alabama at Birmingham, Birmingham, AL.
  • Diaz R; Estudios Cardiológicos Latinoamérica, Rosario, Argentina.
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Toronto, Canada.
  • Hanotin C; Sanofi-Aventis Recherche et Développement S.A., Paris, France; Sanofi-Aventis Recherche et Développement S.A., Bridgewater, NJ.
  • Harrington RA; Stanford University, Stanford, CA.
  • Jukema JW; Leiden University Medical Center, Leiden, the Netherlands.
  • Mahaffey KW; Stanford University, Stanford, CA.
  • Moryusef A; Sanofi-Aventis Recherche et Développement S.A., Paris, France; Sanofi-Aventis Recherche et Développement S.A., Bridgewater, NJ.
  • Pordy R; Regeneron Therapeutics, Tarrytown, NY.
  • Roe MT; Duke Clinical Research Institute, Durham, NC.
  • Rorick T; Duke Clinical Research Institute, Durham, NC.
  • Sasiela WJ; Regeneron Therapeutics, Tarrytown, NY.
  • Shirodaria C; Covance, Inc.,Maidenhead, and Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
  • Szarek M; State University of New York Downstate Medical Center, Brooklyn, NY.
  • Tamby JF; Sanofi-Aventis Recherche et Développement S.A., Paris, France; Sanofi-Aventis Recherche et Développement S.A., Bridgewater, NJ.
  • Tricoci P; Duke Clinical Research Institute, Durham, NC.
  • White H; Auckland City Hospital and University of Auckland, Auckland, New Zealand.
  • Zeiher A; Johann Wolfgang Goethe University, Frankfurt, Germany.
  • Steg PG; Assistance Publique-Hôpitaux de Paris, INSERM U-1148, Université Paris Diderot, Paris, France.
Am Heart J ; 168(5): 682-9, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25440796
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article